Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
OPERATING ACTIVITIES:
Net loss	$ (677,165)	$ (10,154)
Adjustments to reconcile net loss to cash flows provided by (used in) operating activities:
Amortization of debt issuance costs		71,860
Gain on derecognition of certain accounts payable and accrued expenses		(1,064,480)
Changes in operating assets and liabilities
Prepaid expenses		11,145
Assets held for sale		12,000
Accounts payable	36,678	(19,001)
Accrued expenses
Accounts payable related party		(1,000)
Accrual for settlement of lawsuits	187,686	475,623
Accrued interest – related parties	453,745	384,823
Net cash provided by (used in) operating activities	944	(139,184)
INVESTING ACTIVITIES:
Proceeds from the sale of assets
Net cash provided by investing activities
FINANCING ACTIVITIES:
Cash received on exercise of common stock option		25,000
Cash proceeds from convertible promissory notes		113,000
Net cash provided by financing activities		138,000
INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS	944	(1,184)
CASH AND CASH EQUIVALENTS, beginning of period	1,001	2,185
CASH AND CASH EQUIVALENTS, end of period	1,945	1,001
Supplemental cash flow disclosures
Cash paid for interest cost		14,101
Income taxes paid
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Debt discount on convertible notes payable		38,000
Common stock issued		25,000
Settlement of liabilities through direct payment by related party	205,655
Conversions into common stock of convertible debt and accrued interest		265,843
Related party promissory note settled by exercise of options	$ 192,080